Helping to Bring Improved and Novel Therapies to the Right Patient Population Faster
NTRC Precision Medicine Services is now Oncolines
As an independent company, Oncolines will now be singularly focused on [...]
[Webinar] Comparative Cancer Cell Panel Profiling of Recently Approved Kinase Inhibitors
Kinases are the major anticancer drug target class of the 21st century1 [...]
Case study: Altered drug response in 3D spheroids
May 25, 2021: A new case study is [...]
- Case study – Pharmacological models to assess the role of tryptophan-metabolizing enzymes in cancerNTRC Oncolines2021-02-12T10:20:52+01:00
- Case study – Synergistic interaction of olaparib and cisplatinNTRC Oncolines2021-02-11T17:59:29+01:00
PREMIUM BENEFITS OF ONCOLINES PRECISION MEDICINE SERVICES: Cell-Based Assays, Drug Combinations, High-Throughput Screening
Integration of cancer biology and big data analysis
Identification of patient selection markers
Side-by-side comparison with known anti-cancer agents
Discovery of targeted and novel synergistic drug combinations
Science-driven technology platforms
Short turnaround times
